These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10354548)

  • 1. Delivery of DNA vaccines by attenuated intracellular bacteria.
    Dietrich G; Gentschev I; Hess J; Ulmer JB; Kaufmann SH; Goebel W
    Immunol Today; 1999 Jun; 20(6):251-3. PubMed ID: 10354548
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines.
    Dietrich G; Kolb-Mäurer A; Spreng S; Schartl M; Goebel W; Gentschev I
    Vaccine; 2001 Mar; 19(17-19):2506-12. PubMed ID: 11257384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G; Spreng S; Gentschev I; Goebel W
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of protein antigens and DNA by attenuated intracellular bacteria.
    Gentschev I; Dietrich G; Spreng S; Pilgrim S; Stritzker J; Kolb-Mäurer A; Goebel W
    Int J Med Microbiol; 2002 Feb; 291(6-7):577-82. PubMed ID: 11890559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bacterial systems for the delivery of recombinant protein or DNA.
    Spreng S; Dietrich G; Niewiesk S; ter Meulen V; Gentschev I; Goebel W
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):299-304. PubMed ID: 10727885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of non-pathogenic gram(+) and gram(-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved.
    Dogi CA; Weill F; Perdigón G
    Immunobiology; 2010; 215(1):60-9. PubMed ID: 19250703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial ghosts as adjuvant particles.
    Riedmann EM; Kyd JM; Cripps AW; Lubitz W
    Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial ghosts as antigen delivery vehicles.
    Mayr UB; Walcher P; Azimpour C; Riedmann E; Haller C; Lubitz W
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1381-91. PubMed ID: 15878634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent DNA-based vectors for DNA vaccine delivery.
    Roh YH; Lee K; Ye JJ; Luo D
    Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Hybrid Biological-Biomaterial Vector for Antigen Delivery.
    Qi R; Hill A; Pfeifer BA
    Methods Mol Biol; 2021; 2183():461-475. PubMed ID: 32959260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles for the delivery of DNA vaccines.
    O'Hagan DT; Singh M; Ulmer JB
    Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant attenuated bacteria for the delivery of subunit vaccines.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Brinkmann V; Grode L; Hess J; Kaufmann SH; Goebel W
    Vaccine; 2001 Mar; 19(17-19):2621-8. PubMed ID: 11257401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H2M3wt-restricted, Listeria monocytogenes-immune CD8 T cells respond to multiple formylated peptides and to a variety of gram-positive and gram-negative bacteria.
    Nataraj C; Huffman GR; Kurlander RJ
    Int Immunol; 1998 Jan; 10(1):7-15. PubMed ID: 9488151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.